文献速递关节外科

全髋关节置换术中的双动关节:混合股骨与髋臼组件是一种可行选择

Dual Mobility Articulation in Total Hip Arthroplasty: Mixed Femoral and Acetabular Components are a Feasible Option.
PubMed 文献 · J Arthroplasty · 2024-01-14

该回顾性研究纳入2011至2017年全髋置换翻修术中植入的双动关节130髋,平均随访7年,其中混合生产商组件103髋、匹配组件27髋;两组全因再手术、脱位、无菌性松动无显著差异,匹配组件组假体内脱位率较高(11%对0.97%),生存分析2、5、10年结果相似。作者认为在合适患者中混合生产商双动关节的标签外使用是可行且安全的选择。

要点

  • 混合组件与匹配组件在全因再手术、脱位、无菌性松动率上无显著差异。
  • 匹配组件组假体内脱位率较高(11%对0.97%)。
  • 当股骨柄或髋臼杯固定良好时,混合组件双动关节可能减少患者病残并避免翻修全部组件。

核心结论

  • 混合组件双动关节与匹配组件相比显示出相似的结果。
  • 在合适患者中,全髋关节置换术中标签外使用混合生产商双动关节是一种可行且安全的选择。
  • 当遇到固定良好的股骨柄或髋臼杯时,使用混合组件双动关节可能减少患者病残并避免翻修全部组件。

研究设计与样本

  • 回顾性综述2011至2017年全髋关节置换翻修术中植入的双动关节。
  • 研究纳入130髋,平均随访7年,分为匹配组件组27髋和混合组件组103髋。
  • 采用卡方检验和Fisher精确检验比较全因再手术、翻修、假体内脱位、脱位和无菌性松动率,并进行生存分析。

主要发现

  • 匹配组件组与混合组件组的全因再手术率分别为33%和25.2%,无显著差异。
  • 匹配组件组与混合组件组的脱位率分别为14.8%和7.7%,无显著差异。
  • 匹配组件组与混合组件组的无菌性松动率分别为3.7%和3.9%,无显著差异。
  • 匹配组件组假体内脱位率为11%,混合组件组为0.97%,匹配组件组较高。
  • 生存分析显示2年、5年和10年结果相似。

临床怎么用

  • 作者认为,在合适患者中,全髋关节置换术中标签外使用混合生产商双动关节是一种可行且安全的选择。
  • 作者认为,当遇到固定良好的股骨柄或髋臼杯时,使用混合组件双动关节可能减少患者病残并避免翻修全部组件。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The utilization of a different manufacturer for the prosthetic femoral head and the polyethylene insert in dual mobility (DM) for total hip arthroplasty (THA) may be necessary, especially in the revision setting. However, there is no data in the literature about this application. This study evaluated the outcomes of mixed manufacturer components, with the hypothesis that there would be no difference in measured outcomes compared to matched components. METHODS: The DM articulations implanted during THA revision were retrospectively reviewed from 2011 to 2017. The study group was then stratified into 2 cohorts: matching components or mixed components. Of 130 hips included in the study with DM articulations with average follow-up of 7 years, 103 had mixed and 27 had matching manufacturer components. Rates of all cause reoperation and revision, intraprosthetic dislocation, dislocation, and aseptic loosening were compared using Chi-squared and Fisher's exact test; survival analysis was also performed. RESULTS: Matched and mixed manufacturer implants had no significant difference between all cause reoperation (33 versus 25.2%), dislocation (14.8 versus 7.7%), and aseptic loosening (3.7 versus 3.9%), respectively. Higher rates of intraprosthetic dislocation (11 versus 0.97%) were observed in the matching component cohort. Survival analysis showed similar outcomes at 2, 5, and 10 years. CONCLUSIONS: Mixed-component DM articulations show similar results compared to matching components. The off-label use of mixed manufacture DM articulation in THA is a feasible and safe option in the correct patient. Furthermore, when encountering a well-fixed femoral stem or acetabular shell, the use of a mixed component DM articulations may reduce the morbidity for the patient and prevent revision of all components.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Holland C, Cochrane N, Hinton Z, et al. Dual Mobility Articulation in Total Hip Arthroplasty: Mixed Femoral and Acetabular Components are a Feasible Option. J Arthroplasty. 2024. PMID: 38220027. doi:10.1016/j.arth.2024.01.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。